2006 related articles for article (PubMed ID: 17018149)
1. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
2. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A
Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955
[TBL] [Abstract][Full Text] [Related]
4. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
5. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis.
Segal I; Yaakov Y; Adler SN; Blau H; Broide E; Santo M; Yahav Y; Klar A; Lerner A; Aviram M; Ellis I; Mountford R; Shteyer E; Kerem E; Wilschanski M
J Clin Gastroenterol; 2008 Aug; 42(7):810-4. PubMed ID: 18360295
[TBL] [Abstract][Full Text] [Related]
9. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
Sands D
Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
[TBL] [Abstract][Full Text] [Related]
10. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
11. Nasal potential difference in congenital bilateral absence of the vas deferens.
Pradal U; Castellani C; Delmarco A; Mastella G
Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
[TBL] [Abstract][Full Text] [Related]
12. Screening for cystic fibrosis: the importance of using the correct tools.
Shah U; Moatter T
J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
[TBL] [Abstract][Full Text] [Related]
13. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
[TBL] [Abstract][Full Text] [Related]
14. Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis.
Gonska T; Ip W; Turner D; Han WS; Rose J; Durie P; Quinton P
Thorax; 2009 Nov; 64(11):932-8. PubMed ID: 19734129
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals.
Mishra A; Greaves R; Smith K; Carlin JB; Wootton A; Stirling R; Massie J
J Pediatr; 2008 Dec; 153(6):758-63. PubMed ID: 18589442
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
[TBL] [Abstract][Full Text] [Related]
18. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'ava-Santucci J; Dusser D
J Cyst Fibros; 2004 Mar; 3(1):15-22. PubMed ID: 15463882
[TBL] [Abstract][Full Text] [Related]
20. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
